(G21.1) Other drug-induced secondary parkinsonism

More details coming soon

Icon
395 290 in individuals diagnosis other drug-induced secondary parkinsonism confirmed
Icon
22 723 deaths with diagnosis other drug-induced secondary parkinsonism
Icon
6% mortality rate associated with the disease other drug-induced secondary parkinsonism

Diagnosis other drug-induced secondary parkinsonism is diagnosed Women are 1.08% more likely than Men

195 505

Men receive the diagnosis other drug-induced secondary parkinsonism

13 152 (6.7 %)

Died from this diagnosis.

100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
199 785

Women receive the diagnosis other drug-induced secondary parkinsonism

9 571 (4.8 %)

Died from this diagnosis.

Risk Group for the Disease other drug-induced secondary parkinsonism - Men aged 75-79 and Women aged 80-84

Icon
In Men diagnosis is most often set at age 5-9, 15-95+
Icon
Less common in men the disease occurs at Age 0-5, 10-14Less common in women the disease occurs at Age 0-14
Icon
In Women diagnosis is most often set at age 15-95+

Disease Features other drug-induced secondary parkinsonism

Icon
Absence or low individual and public risk
Icon

Other drug-induced secondary parkinsonism - what does this mean

Other drug-induced secondary parkinsonism is a type of parkinsonism caused by certain medications that interfere with the normal functioning of the brain. these medications can cause a decrease in dopamine levels in the brain, which can lead to the signs and symptoms of this disorder, such as muscle rigidity, tremor, and slowed movement.

What happens during the disease - other drug-induced secondary parkinsonism

Other drug-induced secondary parkinsonism is a neurological disorder caused by the long-term use of certain drugs that can interfere with the normal functioning of the brain. these drugs can reduce the amount of dopamine, a neurotransmitter that plays a key role in controlling movement, leading to the symptoms of parkinson's disease, such as tremors, muscle stiffness, and difficulty with balance and coordination. additionally, the drugs may cause damage to the neurotransmitters in the brain, further contributing to the symptoms of parkinson's.

Clinical Pattern

More details coming soon

How does a doctor diagnose

  • Physical examination
  • Neurological examination
  • Blood tests
  • MRI/CT scan
  • Electroencephalogram (EEG)
  • Urine tests
  • Lumbar puncture (spinal tap)
  • Genetic testing
  • Drug screening

Treatment and Medical Assistance

Main Goal: To reduce symptoms and improve quality of life for a patient with drug-induced secondary parkinsonism.
  • Review patient's medical history and current medications
  • Monitor and adjust medications as needed
  • Prescribe medications to reduce symptoms
  • Refer patient for physical therapy
  • Refer patient for occupational therapy
  • Refer patient for speech therapy
  • Refer patient for cognitive therapy
  • Refer patient for psychiatric evaluation
  • Refer patient for deep brain stimulation
  • Refer patient for surgical treatment
Icon
28 Days of Hospitalization Required
Icon
Average Time for Outpatient Care Not Established

Other drug-induced secondary parkinsonism - Prevention

The prevention of drug-induced secondary parkinsonism is to avoid the use of medications that are known to be associated with this condition, such as antipsychotics, antiemetics, and anticonvulsants. additionally, it is important to monitor the use of these medications and to be aware of any potential side effects. if any of these side effects are noticed, the medication should be stopped immediately and the patient should be referred to a medical professional for further evaluation.